Markus Reitmajer

Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Cancer survivorship in malignant melanoma.

Cancer survivorship in malignant melanoma.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: March 02, 2026

Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study.

Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter study.

Journal: The oncologist
Published: December 15, 2025

Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.

Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.

Journal: Biology
Published: November 03, 2025

Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020.

Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 24, 2025

Precision medicine in cutaneous melanoma-A comprehensive review.

Precision medicine in cutaneous melanoma-A comprehensive review.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 08, 2025

Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021.

Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021.

Journal: International journal of cancer
Published: May 29, 2025

Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation.

Adjuvant anti-PD-1 therapy improves melanoma-specific survival in stage IIIC-IV melanoma patients with high tumor mutation burden and BRAF V600 mutation.

Journal: Frontiers in oncology
Published: April 26, 2025

Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: February 24, 2025

Distress and Its Determinants in 820 Consecutive Melanoma Patients.

Distress and Its Determinants in 820 Consecutive Melanoma Patients.

Journal: Cancer medicine
Published: December 17, 2024

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2.

Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2.

Journal: Therapeutic advances in medical oncology
Published: November 25, 2024

Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire study.

Psychosocial distress and persistent adverse events in long-term survivors of stage IV melanoma - a cross-sectional questionnaire study.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: October 30, 2024

Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics.

Determining the role of basophil activation testing in reported type 1 allergy to beta-lactam antibiotics.

Journal: Frontiers in allergy
Published: October 17, 2024
Showing 1-12 of 16

Last Updated: 09/26/2026